Volunteer for NIAID-funded clinical studies related to transplantation on ClinicalTrials.gov.
The goal of NIAID transplantation research is to improve the long-term success of organ, tissue, and cell transplantation by understanding the role the immune system plays in transplant success or failure. NIAID-supported investigators are working to selectively eliminate unwanted immune responses, while maintaining the immune system's ability to fight infection and cancer. The aim is to modify the immune response in a way that will improve long-term transplant survival and reduce the need for broadly immunosuppressive medications, which can cause significant side effects.
Protein-Based Urine Test Predicts Kidney Transplant Outcomes—Aug. 22, 2013
Urine Test Can Diagnose, Predict Kidney Transplant Rejection—July 3, 2013
Gene Pattern May Identify Kidney Transplant Recipients Who Don’t Need Life-long Anti-rejection Drugs—May 24, 2010
Blood Stem-Cell Transplant Regimen Reverses Sickle Cell Disease in Adults—Dec. 9, 2009
HHS Statement: National Donate Life Month—April 13, 2009
All Transplantation News Releases
News from NIAID-Supported Institutions
Last Updated August 22, 2013
Last Reviewed December 07, 2010